| |
 |
|
Class Information
Number: 514/12
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Peptide containing (e.g., protein, peptones, fibrinogen, etc.) doai > 25 or more peptide repeating units in known peptide chain structure
Description: Subject matter wherein a peptide chain has 25 or more peptide units in an uninterrupted chain.
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 7618944 |
Encapsulated amyloid-beta peptides |
Nov. 17, 2009 |
| 7618943 |
Fusion polypeptides, and use thereof in antivascular tumor therapy |
Nov. 17, 2009 |
| 7615534 |
Antimicrobial peptides and use thereof |
Nov. 10, 2009 |
| 7615212 |
Compositions and methods for the systemic treatment of arthritis |
Nov. 10, 2009 |
| 7612043 |
Method of reducing or inhibiting ObR signaling using a leptin antagonist consisting of SEQ id No: 2 |
Nov. 3, 2009 |
| 7612042 |
Methods for inhibiting heregulin and treating cancer |
Nov. 3, 2009 |
| 7612041 |
Isolated activin-binding ActRIIa polypeptide comprising the SEQ ID NO: 7 and uses for promoting bone growth |
Nov. 3, 2009 |
| 7612040 |
Lefty polypeptides and derivatives thereof |
Nov. 3, 2009 |
| 7612039 |
Method of cell growth inhibition with agnoprotein |
Nov. 3, 2009 |
| 7612038 |
Biglycan and related therapeutics and methods of use |
Nov. 3, 2009 |
| 7611867 |
CC-chemokine binding tick proteins |
Nov. 3, 2009 |
| 7611699 |
Methods of using cytokine zalpha11 ligand |
Nov. 3, 2009 |
| 7608589 |
Peptidyl diacylglycerides |
Oct. 27, 2009 |
| 7608588 |
Mineral collagen chelates and methods of making and using same |
Oct. 27, 2009 |
| 7608587 |
Exendin 4 polypeptide fragment |
Oct. 27, 2009 |
| 7608586 |
Soluble low-density lipoprotein receptor related protein binds directly to Alzheimer's amyloid-beta peptide |
Oct. 27, 2009 |
| 7608585 |
Compositions for inhibition of necrosis induced by a neurotrophin |
Oct. 27, 2009 |
| 7608584 |
Calcitonin drug-oligomer conjugates, and uses thereof |
Oct. 27, 2009 |
| 7608582 |
Delivery vehicle comprising a modified MscL protein channel |
Oct. 27, 2009 |
| 7608579 |
Lung volume reduction using glue compositions |
Oct. 27, 2009 |
| 7608269 |
Compositions and methods for treating cancer by modulating HER-2 and EGF receptors |
Oct. 27, 2009 |
| 7608261 |
VEGF antagonist formulations suitable for intravitreal administration |
Oct. 27, 2009 |
| 7605131 |
EML4-ALK fusion gene |
Oct. 20, 2009 |
| 7605130 |
Albumin-based colloid composition and method of use in treating hypovolemia and multiorgan dysfunction |
Oct. 20, 2009 |
| 7605129 |
Splice variant of human placental growth hormone |
Oct. 20, 2009 |
| 7605128 |
Neurogenerative or neurotrophic factors for mitigating a symptom of ischemia |
Oct. 20, 2009 |
| 7605127 |
Truncated hepatocyte growth factor variant protein HGF/NK2 |
Oct. 20, 2009 |
| 7604993 |
Combined regulation of neural cell production |
Oct. 20, 2009 |
| 7601735 |
Antiviral compounds |
Oct. 13, 2009 |
| 7601693 |
Composition for treating cancer and use thereof |
Oct. 13, 2009 |
| 7601692 |
MCP-1 splice variants and methods of using same |
Oct. 13, 2009 |
| 7601691 |
Anti-obesity agents |
Oct. 13, 2009 |
| 7601685 |
Growth factor modified protein matrices for tissue engineering |
Oct. 13, 2009 |
| 7601516 |
Heterodimeric follicle stimulating hormone-Fc (FSH-Fc) fusion proteins for the treatment of infertility |
Oct. 13, 2009 |
| 7601515 |
Process of high purity albumin production |
Oct. 13, 2009 |
| 7601361 |
Process for providing antimicrobial surfaces |
Oct. 13, 2009 |
| 7601341 |
Vascular endothelial growth factor fusion constructs used to inhibit osteoclastogenesis |
Oct. 13, 2009 |
| 7598222 |
Process for solubilizing glucagon-like peptide 1 compounds |
Oct. 6, 2009 |
| 7598219 |
Implants comprising an osteoinductive factor and a contrast agent compatible therewith |
Oct. 6, 2009 |
| 7598050 |
Methods of identifying compounds that modulate IL-4 receptor-mediated IgE synthesis utilizing a chloride intracellular channel 1 protein |
Oct. 6, 2009 |
| 7595296 |
Mutant polypeptides of fibroblast growth factor 1 |
Sep. 29, 2009 |
| 7595295 |
Use of pleiotrophin to promote neurogeneration |
Sep. 29, 2009 |
| 7595294 |
Vasoactive intestinal polypeptide pharmaceuticals |
Sep. 29, 2009 |
| 7595292 |
Conjugated biological molecules and their preparation |
Sep. 29, 2009 |
| 7595199 |
Method of detecting amyloid-like fibrils or protein aggregates |
Sep. 29, 2009 |
| 7595038 |
Methods of treatment using antibodies to follistatin-3 |
Sep. 29, 2009 |
| 7592509 |
Isolated DNA sequences and polypeptides inducing multiple resistance of plants to phytopathogens and pests |
Sep. 22, 2009 |
| 7592314 |
Use of VEGF and homologues to treat neuron disorders |
Sep. 22, 2009 |
| 7592313 |
Method of stimulating proliferation of regulatory T cells in a diabetic mammal |
Sep. 22, 2009 |
| 7592312 |
Methods of modulating gastrointestinal contractility |
Sep. 22, 2009 |
|
|
|
